Abstract:AimsCopy number variant-sequencing (CNV-seq) and exome sequencing (ES) have been used as powerful tools in understanding the role of genetic variants in congenital heart diseases (CHDs). A few previous large cohort studies have utilized CNV-seq and ES to investigate prenatally diagnosed CHD. Here, we sought to determine the value of CNV-seq and ES for genetic evaluation of foetal CHDs. Methods and resultsWe recruited 398 pregnant women diagnosed with CHDs between 8 January 2017 and 30 November 2020. CNV-seq and ES were performed on foetal and parent samples. CHD cases were classified following the guidelines of the International Paediatric and Congenital Cardiac Code and the Tenth and Eleventh Revisions of the International Classification of Diseases. Data on aneuploids (AUP), pathogenic CNVs (pCNVs), and single nucleotide variants (SNVs) were collected and compared, following appropriate procedures. We identified genetic abnormalities in 129 (32.41%) foetuses. These abnormalities included AUP (10.80%), pCNVs (13.32%), and SNVs (8.04%). ES analysis yielded higher SNVs in cases without AUP or pCNVs. Non-isolated CHDs were associated with higher genetic abnormalities than isolated CHDs, mainly due to AUP differences between the two groups. The prevalence of genetic defects was the highest in foetuses with atrioventricular septal defects (AVSD), left ventricular outflow tract obstruction (LVOTO), and conotruncal defects (CTD). AVSD and anomalies of atrioventricular junctions and valves were associated with AUP abnormalities. CTD, anomalies of extrapericardial arterial trunks, and anomalies of the ventricular outflow tracts were the most common CHD categories diagnosed using CNVs. The most common CHDs associated with single ventricle (SV) abnormalities were heterotaxy (Hex) (14.89%), LVOTO (14.58%), and ventricular septal defect (VSD) (26.67%, 4/15). Although the ES yields were higher than CNV-seq for VSD (44.4%, 4/9), LVOTO (20%, 7/35), Hex (14.89%, 7/47), and CTD (9.1%, 11/121), its diagnostic yield did not increase for SV (6.7%, 1/15), AVSD (3.8%, 1/26), or right ventricular obstruction defects (2.6%, 1/38). The most common mutations were observed in KMT2D, CHD7, and NOTCH1. ConclusionsTo our knowledge, this is the largest cohort study to investigate the incidence of SNVs using ES in foetal CHD. CNV-seq and ES identified genetic abnormalities in nearly 1/3 of foetal CHD cases. Thus, CNV-seq and ES can provide clinically relevant information for pregnancy management.

Analysis of Copy Number Variations by Low-Depth Whole-Genome Sequencing in Fetuses with Congenital Cardiovascular Malformations

EP06.06: Analysis of Copy Number Variations in Fetal Conotruncal Heart Defects Using Low‐coverage Whole Genome Sequencing

Chromosomal Microarray Analysis in Fetuses with Congenital Anomalies of the Kidney and Urinary Tract: A Prospective Cohort Study and Meta‐analysis

Detection of Copy Number Variants by Next-Generation Sequencing in Fetuses with Congenital Heart Disease

Detection of copy number variants using chromosomal microarray analysis for the prenatal diagnosis of congenital heart defects with normal karyotype.

Clinical Application Of Chromosomal Microarray Analysis For The Prenatal Diagnosis Of Chromosomal Abnormalities And Copy Number Variations In Fetuses With Congenital Heart Disease (Vol 38, Pg 406, 2018)

Clinical Application of Chromosomal Microarray Analysis in Fetuses with Congenital Heart Disease

Efficiency of copy number variation sequencing combined with karyotyping in fetuses with congenital heart disease and the following outcomes

Detection of copy number variation associated with ventriculomegaly in fetuses using single nucleotide polymorphism arrays

Diagnostic Value of Chromosomal Microarray Analysis for Fetal Congenital Heart Defects with Different Cardiac Phenotypes and Extracardiac Abnormalities

Copy Number Variation Analysis in Chinese Children with Complete Atrioventricular Canal and Single Ventricle

Copy Number Variation Ofgata4andnkx2-5In Chinese Fetuses with Congenital Heart Disease

Genetic aetiology distribution of 398 foetuses with congenital heart disease in the prenatal setting

Analysis of genetic testing in fetuses with congenital heart disease of single atria and/or single ventricle in a Chinese prenatal cohort

Prenatal genetic diagnosis associated with fetal ventricular septal defect: an assessment based on chromosomal microarray analysis and exome sequencing

Prevalence of Chromosomal Abnormalities Identified by Copy Number Variation Sequencing in High-Risk Pregnancies, Spontaneous Abortions, and Suspected Genetic Disorders.

OC26.03: Comparison of the Prevalence of Pathogenic Copy Number Variation in Tetralogy of Fallot and Associated Congenital Heart Defect Diagnosed Between Fetuses and Children

Application value of chromosomal microarray analysis in prenatal diagnosis of lateral ventriculomegaly fetuses

Genome-wide Copy Number Variant Analysis for Congenital Ventricular Septal Defects in Chinese Han Population

Prenatal Diagnosis and Pregnancy Outcomes in Fetuses with Ventriculomegaly

Low-pass Genome Sequencing Reveals Associations Between Copy Number Variations and Fetal Ultrasonographic Anomalies and Soft Markers in a Cohort of 43,721 Fetuses